|
|
 |
|
Viewing report
|
|
|
|
Allergy and Asthma Therapeutics Markets: U.S.
Frost & Sullivan, May 1997
This report on the U.S. markets for allergy and asthma therapeutics includes allergy symptomatic treatment (single-entity antihistamines, antihistamine and decongestant combinations, single-entity topical corticosteroids, nasal corticosteroids, and ophthalmic anti-allergy agents), anti-asthma treatment (sympathomimetics, single-entity xanthines, anticholinergics, inhaled corticosteroids, mast cell stabilizers, and systemic corticosteroids), allergy diagnostic and immunotherapy (allergy diagnostics, and immunotherapy), and anti-asthma medical devices (nebulizers and peak-flow monitors).
Customers who bought this item also bought
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
Respiratory Therapeutics and Devices Markets
Asthma Therapeutics - Global Strategic Business Report
Allergy Drugs - Global Strategic Business Report
U.S. Asthma/COPD Market 2011
The Global Market for Fixed-Dose Combination Drugs for Leading Diseases
Personalized Medicine - Scientific and Commercial Aspects
Pharmaceuticals - Global Outlook
Human Vaccines - Global Strategic Business Report
European Asthma and Rhinitis Therapeutic Product Markets
|
|
|
|
